Companies: 10,795·Total market cap: $144.5T
Revive Therapeutics Ltd.

Revive Therapeutics Ltd.

RVVTFOTCHealthcare● Active
$0.03
+$0.00(+17.69%)
Market Cap$11074888
P/E Ratio
52W High$0.059
52W Low$0.006

Revive Therapeutics Ltd.(RVVTF)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · RVVTF · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-062024-062023-062022-062021-06
Revenue
Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Cost of Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Gross Profit$0.00B$0.00B($0.00B)($0.00B)($0.00B)
Gross Margin %(computed)
Operating Expenses
R&D Expenses$0.00B$0.00B$0.00B$0.02B$0.01B
G&A Expenses$0.00B$0.00B$0.00B$0.00B$0.01B
Total Operating Expenses$0.00B$0.00B$0.01B$0.02B$0.02B
Operating Income($0.00B)($0.00B)($0.01B)($0.02B)($0.02B)
Operating Margin %(computed)
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Income Before Tax($0.01B)($0.01B)($0.01B)($0.02B)($0.02B)
Income Tax Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Net Income($0.01B)($0.01B)($0.01B)($0.02B)($0.02B)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-0.03$-0.01$-0.02$-0.06$-0.08
Wtd Avg Shares0.42B0.38B0.34B0.32B0.27B
EBITDA($0.01B)($0.00B)($0.01B)($0.02B)($0.02B)
EBITDA Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · CAD · B

深入了解Revive Therapeutics Ltd.

关于Revive Therapeutics Ltd.(RVVTF)损益表

Revive Therapeutics Ltd.(RVVTF)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,RVVTF实现营收$0.00B,毛利润$0.00B(毛利率—),净利润($0.01B)(净利率—)。

常见问题

RVVTF · 4 问

Revive Therapeutics Ltd.(RVVTF)2025财年营收为$0.00B,同比down—%。

RVVTF revenueRVVTF salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09